In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...